FDA Import Refusal 1FX-6573334-6/10002/1 — RENATA PHARMA

RENATA PHARMA — FEI 3037752770

The FDA refused shipment 1FX-6573334-6/10002/1 from RENATA PHARMA (Bangladesh) on May 8, 2026. The refused product falls under Drugs and Biologics — REVLIMID. Cited charge: 75 This firm has 1 other import refusal on record.

Refusal details

Date
May 8, 2026
Country
Bangladesh
Product Category
Drugs and Biologics
Product Code
61CCE03 REVLIMID
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.